Fisetin-loaded chitosan nanoparticles ameliorate pilocarpine-induced temporal lobe epilepsy and associated neurobehavioral alterations in mice: Role of ROS/TNF-α-NLRP3 inflammasomes pathway
- PMID: 38740358
- DOI: 10.1016/j.nano.2024.102752
Fisetin-loaded chitosan nanoparticles ameliorate pilocarpine-induced temporal lobe epilepsy and associated neurobehavioral alterations in mice: Role of ROS/TNF-α-NLRP3 inflammasomes pathway
Abstract
Fisetin has displayed potential as an anticonvulsant in preclinical studies yet lacks clinical validation. Challenges like low solubility and rapid metabolism may limit its efficacy. This study explores fisetin-loaded chitosan nanoparticles (NP) to address these issues. Using a murine model of pilocarpine-induced temporal lobe epilepsy, we evaluated the anticonvulsant and neuroprotective effects of fisetin NP. Pilocarpine-induced seizures and associated neurobehavioral deficits were assessed after administering subtherapeutic doses of free fisetin and fisetin NP. Changes in ROS, inflammatory cytokines, and NLRP3/IL-18 expression in different brain regions were estimated. The results demonstrate that the fisetin NP exerts protection against seizures and associated depression-like behavior and memory impairment. Furthermore, biochemical, and histological examinations supported behavioral findings suggesting attenuation of ROS/TNF-α-NLRP3 inflammasome pathway as a neuroprotective mechanism of fisetin NP. These findings highlight the improved pharmacodynamics of fisetin using fisetin NP against epilepsy, suggesting a promising therapeutic approach against epilepsy and associated behavioral deficits.
Keywords: Anti-inflammatory effect; Antioxidant; Chitosan nanoformulation; Fisetin; Temporal lobe epilepsy.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare no conflict of interest.
Similar articles
-
Mechanism of NLRP3 Inflammasome in Epilepsy and Related Therapeutic Agents.Neuroscience. 2024 May 14;546:157-177. doi: 10.1016/j.neuroscience.2024.03.029. Epub 2024 Apr 3. Neuroscience. 2024. PMID: 38574797 Review.
-
Characterisation of NLRP3 pathway-related neuroinflammation in temporal lobe epilepsy.PLoS One. 2022 Aug 16;17(8):e0271995. doi: 10.1371/journal.pone.0271995. eCollection 2022. PLoS One. 2022. PMID: 35972937 Free PMC article.
-
Fisetin ameliorates cognitive impairment by activating mitophagy and suppressing neuroinflammation in rats with sepsis-associated encephalopathy.CNS Neurosci Ther. 2022 Feb;28(2):247-258. doi: 10.1111/cns.13765. Epub 2021 Nov 27. CNS Neurosci Ther. 2022. PMID: 34837343 Free PMC article.
-
Fisetin mitigates hepatic ischemia-reperfusion injury by regulating GSK3β/AMPK/NLRP3 inflammasome pathway.Hepatobiliary Pancreat Dis Int. 2021 Aug;20(4):352-360. doi: 10.1016/j.hbpd.2021.04.013. Epub 2021 May 8. Hepatobiliary Pancreat Dis Int. 2021. PMID: 34024736
-
TRPV4-induced inflammatory response is involved in neuronal death in pilocarpine model of temporal lobe epilepsy in mice.Cell Death Dis. 2019 May 16;10(6):386. doi: 10.1038/s41419-019-1612-3. Cell Death Dis. 2019. PMID: 31097691 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous